Please provide your email address to receive an email when new articles are posted on . Pacemakers or implanted cardiac defibrillators that were retrieved postmortem, resterilized and reused in ...

Medtronic CRT-D Devices Demonstrate Survival Benefits for Mildly Symptomatic Heart Failure Patients in Two Pivotal Clinical Trials MINNEAPOLIS – Medtronic, Inc. today announced that the U.S. Food and ...

Dr. Hunter Champion answers the question: 'What Is A Biventricular Pacemaker?' — -- Question: What is a biventricular pacemaker or cardiac resynchronization therapy (also called a CRT device), ...

Wearable electronic devices such as smart watches, worn by consumers to monitor their health, could interfere with the correct working of cardiac implantable electronic devices (CIEDs), posing serious ...

Multiple societies covering cardiovascular medicine, electrophysiology, heart failure, and imaging have released updated appropriate use criteria (AUC) for various cardiac implantable electronic ...

In today’s world we have come to rely on our devices, such as smartphones, tablets and laptops, as a key element in all aspects of our lives. Whether it’s letting loved ones know we’re on our way, ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. An implantable device that shocks an erratically beating heart back into ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

Results from the Cardiac Resynchronization—Heart Failure (CARE-HF) study support the use of implantable cardiac-resynchronization devices in patients with heart failure due to left-ventricular ...

The U.S. cardiac resynchronization therapy market was valued at $965.6 million in 2019, and is projected to reach $983.3 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Surge in ...